Acetaminophen/Amantadine/Loratadine

对乙酰氨基酚/金刚烷胺/氯雷他定

Report date: 2022/03/22 11:03:21

Base Information

Drug NameAcetaminophen/Amantadine/Loratadine
Drug Alias NameLoratadine/Acetaminophen/Amantadine氯雷他定/对乙酰氨基酚/金刚烷胺金刚烷胺/氯雷他定/对乙酰氨基酚
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsGlutamate [NMDA] receptor antagonistsCyclooxygenases inhibitors
TargetsHistamine H1 receptorGlutamate [NMDA] receptorCyclooxygenases
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Amantadine HydrochlorideLoratadineAcetaminophen
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesLiomont
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiomont
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A